- Home
- ANGH vs TRIB Comparison
ANGH vs TRIB Comparison
Compare ANGH & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANGH | TRIB |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United Arab Emirates | Ireland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 18.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ANGH | TRIB |
|---|---|---|
| Price | $2.65 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 83.5K |
| Earning Date | 04-30-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $78,093,405.00 | $61,555,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 88.72 | 8.31 |
| 52 Week Low | $2.46 | $0.48 |
| 52 Week High | $8.88 | $3.44 |
Technical Indicators
Market Signals| Indicator | ANGH | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 28.69 | 56.07 |
| Support Level | $2.50 | $1.04 |
| Resistance Level | $3.00 | $1.22 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 11.11 | 59.97 |
Price Performance
Historical ComparisonAbout ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.